UPDATE : Monday, September 7, 2020
상단여백
HOME Pharma
MGmed to change name to Cancer Rop
  • By Marian Chu
  • Published 2017.12.13 18:14
  • Updated 2017.12.13 18:14
  • comments 0

Korean pharmaceutical MGmed decided to change the company’s name to Cancer Rop Co. to refocus company efforts on developing cancer drugs, at a general shareholders’ meeting Wednesday.

MGmed, established in 2001, had specialized in developing molecular diagnostic techniques for various genetic diseases.

The company also named Lee Jang-woo as its new CEO.

yjc@docdocdoc.co.kr

<© Korea Biomedical Review, All rights reserved.>

Other articles by Marian Chu
iconMost viewed
  • ‘Cyramza helped improve gastric cancer treatment in Korea’
  • ‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
  • Amgen Korea wins new indication for acute lymphoblastic leukemia drug
  • SNUBH develops AI model predicting patients at risk of cerebral aneurysm
  • Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
    • ‘Cyramza helped improve gastric cancer treatment in Korea’ ‘Cyramza helped improve gastric cancer treatment in Korea’
    Comments 0
    More
    0/300
    Please leave the first comment.
    176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
    여백
    Most viewed
    여백
    Opinion
    [Column] Correct diagnosis leads to proper treatment
    [Column] Correct diagnosis leads to proper treatment
    [Column] How ongoing doctors’ strike is different from 20 years ago
    [Column] How ongoing doctors’ strike is different from 20 years ago
    A Korean-American Doctor asks: Is Korea truly in 2020?
    A Korean-American Doctor asks: Is Korea truly in 2020?
    여백
    Back to Top